DR. BALDEV S. PRAJAPATI

Size: px
Start display at page:

Download "DR. BALDEV S. PRAJAPATI"

Transcription

1 DR. BALDEV S. PRAJAPATI D. Ped; MD (Ped.); Gold Medalist FIAP; MNAMS. FICMCH HOD & Professor, GCS Medical College, Hospital & Research Centre, Ahmedabad. Popular Teacher Examiner: UG, M.D;DNB Across the country, OSCE Expert. FIAP 2005 Executive Board Member, Central IAP 2002, 2003, 2005, 2006, 2011 Chairperson, ID Chapter, IAP, 2009 Member, IAP Committee on Immunization , President, IAP Gujarat State Branch, 2003 Author : Essential Procedures In Pediatrics Publications : 92

2 Clinical & Diagnostic Features of Cystic Fibrosis

3 Outline Case scenario Cystic Fibrosis (CF) CF in India Basis of CF Clinical Features Laboratory Ixs Sharing our experience Take Home Message

4 Case 1 3 years Male Cough paroxysmal followed by occasional vomiting 20 days, High grade fever 3 days H/o Hosp. 6 times in the past. First Hosp. on 3 DOL for 17 days, diagnosed as septicemia with NEC with prolonged jaundice

5 2 nd Hosp. at age of 17 months for cough, fever and freq. of stool, diagnosed as bronchiolitis 3 rd Hosp. at age of 21 months for fever, cough, freq. of stool and convulsions, diagnosed as acute bronchitis with Rt MZ PN with FS 4 th, 5 th & 6 th Hosp. diagnosed as bronchial asthma (S. IgE 700 IU/ml)

6

7 On Exam. FTT Febrile, tachycardia, tachypnoea, RD R/S, Bil. Rhonchi & creps Clubbing grade II

8 Immunoglobulins WNL Tests for HIV Nonreactive

9

10

11 Dr. BSP

12 Dr. BSP

13 Case 2 8 years Male Cough with yellow sputum 7 days, high grade fever 2 days Treated by local pediatrician with cefixime, antipyretics & antitussive. Hb 9.6, TLC 18,000, P 78, CXR Bronchitis Referred for further management

14 H/o. Hosp. 5 times, 4 times for pneumonia & once for diarrhoea H/o. death of one male sibling at age of 9 years due to LRTI & diarrhoea No H/o TB contact Vaccinated for age

15 Wt kg (25.5) Head 50 cms HT 110 cms (125) Temp o F, PR 130/min, RR 44/min, BP 110/60 SPO 2 91% in room air Clubbing grade II Left lower zone AE, Bil. Creps No murmur, No HS, CNS NAD Hb 10.1, TLC 29,200, P 90, ESR 102, CRP 286, RBS, LFT, RFT, S.electrolytes WNL

16 Inj. Ceftriaxone IVF Paracetamol

17 After 48 hours, Temp o F, PR 140/min, RR 50/min. Toxic Left side AE, VR Liver 3 cm, spleen NP

18

19

20 VATS by pediatric surgeon 45 ml thick yellow fluid aspirated, septae broken, sent for culture ICD inserted Pleural fluid Exam. Proteins 2.6 G/dL, sugar 10 mg/dl, cells 260,P 80 Gram s stain Gram ve bacilli Organisms isolated pseudomonas aeruginosa

21 Inj. Ceftizidime for 3 weeks Chest physiotherapy

22

23 Problems Recurrent pneumonia Diarrhoea FTT H/o. death of one sibling due to LRTI & Diarrhoea Clubbing Empyema with isolation of Pseudomonas

24 Sweat chloride 104 and 90 meq/l Mutation test +ve Cystic Fibrosis

25 Case 3 5 months Male Freq. of stool 8-10/day, semi solid, foul smell, No vomiting, not gaining wt. FTND, Hosp. CSAB, BW kg H/o operation for meconium cyst on third DOL H/o Hosp. 3 times for diarrhoea & not gaining wt.

26 Wt kg Head 37.5 cms length 53 cms vitals stable, FTT, Abd. distended. No HS CBC WNL, Na meq/l, K meq/l, Cl - 78 meq/l, ABG Metabolic alkalosis Sweat chloride 97 meq/l & 102 meq/l Mutation test of child & parents DF 508 Cystic Fibrosis

27 7 months Female Case 4 Referred for recurrent vomiting, diarrhoea & not gaining weight since age of 3 months H/o Hospitalization ADD with severe dehydration Left upper zone pneumonia with FTT with Hypokalemia & nephrocalcinosis (UI) Born to young, non consanguineous parents. FTND / Hosp / CIAB / BW 2.9 kg FTT, Dehydration ++, Lethargic baby. Referred for further management

28

29

30

31

32

33

34 Cystic Fibrosis Presenting as Pseudobartter Syndrome

35 Cystic Fibrosis Cystic Fibrosis (CF) the most common life-limiting recessive genetic disorder in Caucasians incidence approx. 1 in 2500 children born in UK Is it extremely rare in India as it was thought of? No, under diagnosed or missed Rarely suspected, if suspected, not confirmed due to lack of investigative facility Exact incidence in India is not known

36 Cystic Fibrosis Authors No. of pts Diagnosed by Bhakoo et al (1968) 01 Histopathology Mehta et al (1968) 13 Sweat Test Mehta et al (1969) 06 Sweat Test Devi et al (1969) 04 Sweat Test Gupte et al (1970) 06 Sweat Test Reddy et al (1970) 12 Autopsy Venkatraman et al (1972) 01 Autopsy Jagdish JS (1989) 01 Sweat Test Sarkar AK et al (1992) 01 Sweat Test Maiya PP et al (1980) 03 Sweat Test

37 Cystic Fibrosis Authors No. of pts Diagnosed by Prasad ML et al (1990) 02 Autopsy Deivanayagam CN et al (1990) 05 Autopsy Bowlers (1993) 09 Sweat Test & Mutation Test Spencer et al (1994) 13 Sweat Test Powers et al (1996) 20 Sweat Test Singh et al (2002) 18 Sweat Test Kabra et al (2003) 120 Sweat Test & Mutation Test Ashavaid et al (2005) 39 Sweat Test & Mutation Test

38 Delayed diagnosis in India leads to severe malnutrition. Malnutrition is the bad prognostic indicator for survival Early diagnosis & appropriate management may improve the outcome

39 Genetics of CF CF gene identified in 1989, more than 700 mutations have been recognized Most common mutation is delta F508, 70% of total cases. Indian subcontinent, it has been reported between 19 & 44%

40 Basis of disease... The basic defect in CF mutation in the gene for chloride conductance channel i.e. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Results in an abnormality of camp regulated chloride conductance by epithelial cells on mucosal surface Leads to dehydration of secretions that are too viscid & difficult to clear Facilitate chronic infections (P. aeruginosa & staph.aureus most common) Once chronic infection is established, organisms are not eradicated

41 Clinical Manifestations 0 to 2 years Meconium ileus (10-15%) Obstructive jaundice Hyponatremia Hypoproteinemia Steatorrhoea (85%) Salty Kiss FTT Bleeding diathesis Rectal prolapse Staph. pneumonia Bronchitis / Bronchiolitis

42 Clinical Manifestations 2 to 12 years FTT Malabsorption Nasal polyposis Intussusception Recurrent pneumonia

43 More than 13 years Clinical Manifestations Chronic pulmonary disease (70%) Clubbing Pancreatic insufficiency Gall stones Azoospermia Abnormal GTT/DM Chronic intestinal obstruction

44 Atypical Manifestations Appendicitis in Naonates / Infants Pancreatitis Cholelithiasis Rectal prolapse Inguinal Hernia Pseudobartter syndrome Infertility Delayed puberty Dehydration - heart exhaution Diabetes Mellitus Portal Hypertension

45 Clinical features consistent with diagnosis of CF Chronic sino-pulmonary disease manifested by, Recurrent LRTIs Chronic cough & sputum production Airway obstruction manifested by wheezing & air trapping Persistent colonization with typical CF pathogens like P.aeruginosa, staph.aureus, Non-typable HIB, Burkholdelia cepacia

46 Clinical features consistent with diagnosis of CF GIT & Nutritional abnormalities Meconium ileus, Intestinal obstruction, Rectal prolapse Pancreatic insufficiency, Recurrent pancreatitis Biliary or multilobular cirrhosis FTT Hyponatremia Salt loss syndrome Acute salt depletion Metabolic alkalosis Obstructive azoospermia

47 Laboratory Tests Sweat Chloride Test Indications Recurrent / Persistent LRTI Malabsorption Meconium ileus Family H/o CF

48 Sweat Chloride Test Method Sweat collection is carried out by pilocarpine Iontophoresis. Chloride conc. is estimated by titration, flame photometry or by using an ion specific electrode

49 Sweat Chloride Test Interpretation If sweat Cl - > 40 meq/l abnormal repeat the test to confirm If sweat Cl - < 40 meq/l Normal Repeat if strong clinical suspicion If 2 values of sweat Cl - done atleast one week apart >60 meq/l with sweat wt > 100 mg CF If sweat Cl - between meq/l suspected CF Repeat the test after 4-8 weeks/mutation test / other ancillary tests If sweat wt < 100 mg Repeat the test after 4-8 weeks

50 Sweat Chloride Test Genotypically confirmed CF & normal sweat Cl - test has been reported, but rare. They have mild symptoms & may first present in adult life with obstructive azoospermia For reliable results, experienced person is more important Available facility in India Very limited Centers

51 Laboratory Tests Other Investigations Chest x-ray Chest CT Scan LFT, RFT, RBS, S.Ca ++, PO 4, Alkaline phosphtase, S.Na +, K +, Cl -, ABG Mutation Analysis for CF GER studies USG Abdomen Culture of secretions to identify airway colonization

52 Suspect cystic fibrosis in children presenting with recurrent / persistent pneumonia, malabsorption and failure to thrive Sweat test facility available NO Yes Do serum electrolytes, arterial blood gas analysis, culture of respiratory secretions. Stool for fat globules >60 meq/l Perform sweat chloride values meq/l < 40 meq/l Look for hypokalemia, hyponatremia, metabolic alkalosis Pseudomonas in airway secretions, numerous fat globules in stool microscopy Repeat Sweat CI Treat as CF if repeat is > 60 meq/l Repeat Sweat CI Persistent borderline, Try to get mutation analysis Follow up as suspected CF, treat with enzyme replacement, vitamin Label as CF after positive sweat test / mutation studies CF is unlikely investigate for alternative diagnosis

53 Prenatal Diagnosis With the identification of genetic mutations in a child & parents CV at around weeks or amniotic fluid cell culture at weeks of gestation

54 Our Experience Total No of patients: 33 Male: 21 Female: 12 0 to 2 years: 04 2 to 12 years: 26 > 12 years: 03

55 Our Experience FTT: 31 Steatorrhoea: 27 Meconium ileus: 02 Meconium peritonitis: 01 Obtructive jaundice: 01 Bronchitis / Bronchiolitis: 08 Recurrent pneumonia: 22 Staphylococcal pneumonia: 12 Pseudomonas Pneumonia: 06 Malabsorption: 30 Clubbing: 28

56 Take Home Message CF is not rare in India & in Gujarat. It is under diagnosed or missed because it is rarely suspected & if suspected, not confirmed due to lack of investigative facility. Exact incidence in India is not known. Clinical presentation varies from neonates to younger children & adolescents. Any pt. presenting with chronic or recurrent sino pulmonary disease, chronic diarrhoea, malabsorption syndrome, FTT, pancreatic insufficiency or salt loss syndrome without any obvious reason should be investigated for CF. Any child with H/o meconium ileus or prolonged jaundice in neonatal period, CF should be ruled out

57 Take Home Message Delayed diagnosis leads to severe malnutrition, malnutrition is the bad prognostic indicator for survival Clinical diagnosis of CF should be confirmed by sweat chloride test. For reliable results, proper technique and experienced person are important. It should be interpreted in context to other factors. Parents & child should be submitted for mutation test Early diagnosis, adherence to standard protocol in management & regular follow up are quite gratifying With identification of genetic mutations in a child & parents, prenatal diagnosis should be performed

58 Thank You

Cystic Fibrosis. Jennifer McDaniel, BS, RRT-NPS

Cystic Fibrosis. Jennifer McDaniel, BS, RRT-NPS Cystic Fibrosis Jennifer McDaniel, BS, RRT-NPS Overview Cystic fibrosis is the most common fatal, inherited disease in the U. S. CF results from a defective autosomal recessive gene One copy of gene =

More information

"Management and Treatment of Patients with Cystic fibrosis (CF)

Management and Treatment of Patients with Cystic fibrosis (CF) "Management and Treatment of Patients with Cystic fibrosis (CF) Dr. Malena Cohen-Cymberknoh Pediatric Pulmonology and CF Center Hadassah Hebrew-University Medical Center Jerusalem, Israel Afula, March

More information

What is Cystic Fibrosis? CYSTIC FIBROSIS. Genetics of CF

What is Cystic Fibrosis? CYSTIC FIBROSIS. Genetics of CF What is Cystic Fibrosis? CYSTIC FIBROSIS Lynne M. Quittell, M.D. Director, CF Center Columbia University Chronic, progressive and life limiting autosomal recessive genetic disease characterized by chronic

More information

Focus on Cystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis

Focus on Cystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis Focus on (Relates to Chapter 29, Nursing Management: Obstructive Pulmonary Diseases, in the textbook) Copyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Autosomal recessive, multisystem

More information

A review of Cystic Fibrosis

A review of Cystic Fibrosis A review of Cystic Fibrosis Jennifer Landry md F.R.C.P.(C) Pulmonary & Critical Care Medicine McGill University Health Center Cystic Fibrosis One of the most common lethal inherited AR disorders in the

More information

Treating Cystic Fibrosis in Resource Poor Environment

Treating Cystic Fibrosis in Resource Poor Environment Treating Cystic Fibrosis in Resource Poor Environment SK Kabra, M Kabra, R Lodha, S Shastri Department of Pediatrics All India Institute of Medical Sciences New Delhi India Corresponding author: S K Kabra,

More information

Goals Basic defect Pathophysiology Clinical i l signs and symptoms Therapy

Goals Basic defect Pathophysiology Clinical i l signs and symptoms Therapy CYSTIC FIBROSIS Lynne M. Quittell, M.D. Director, CF Center Columbia University Goals Basic defect Pathophysiology Clinical i l signs and symptoms Therapy What is Cystic Fibrosis? Chronic, progressive

More information

FACTS ABOUT. Cystic Fibrosis. What Is Cystic Fibrosis. What Are the Signs and Symptoms of CF?

FACTS ABOUT. Cystic Fibrosis. What Is Cystic Fibrosis. What Are the Signs and Symptoms of CF? FACTS ABOUT Cystic Fibrosis What Is Cystic Fibrosis Cystic fibrosis (CF) is a chronic, progressive, and frequently fatal genetic (inherited) disease of the body s mucus glands. CF primarily affects the

More information

CYSTIC FIBROSIS OBJECTIVES NO CONFLICT OF INTEREST TO DISCLOSE

CYSTIC FIBROSIS OBJECTIVES NO CONFLICT OF INTEREST TO DISCLOSE CYSTIC FIBROSIS Madhu Pendurthi MD MPH Staff Physician, Mercy Hospital Springfield, MO NO CONFLICT OF INTEREST TO DISCLOSE OBJECTIVES Epidemiology of Cystic Fibrosis (CF) Genetic basis and pathophysiology

More information

Cystic Fibrosis. Advances and Asian Perspective Dr AS Paul 13 October 06

Cystic Fibrosis. Advances and Asian Perspective Dr AS Paul 13 October 06 Cystic Fibrosis Advances and Asian Perspective Dr AS Paul 13 October 06 Cystic Fibrosis An Overview Asian Perspective Advances Cystic Fibrosis An Overview Epidemiology and Pathogenesis Most common severe

More information

Diseases of the gastrointestinal system. H Awad Lecture 2: small intestine/ part 2 and appendix

Diseases of the gastrointestinal system. H Awad Lecture 2: small intestine/ part 2 and appendix Diseases of the gastrointestinal system H Awad Lecture 2: small intestine/ part 2 and appendix Malabsorption most important causes of malabsorption: Celiac disease tropical sprue Lactase deficiency Whipple

More information

Cystic Fibrosis. Parkland College. Monica Rahman Parkland College. Recommended Citation

Cystic Fibrosis. Parkland College. Monica Rahman Parkland College. Recommended Citation Parkland College A with Honors Projects Honors Program 2013 Cystic Fibrosis Monica Rahman Parkland College Recommended Citation Rahman, Monica, "Cystic Fibrosis" (2013). A with Honors Projects. 98. http://spark.parkland.edu/ah/98

More information

Changes in the management of children with Cystic Fibrosis. Caroline Murphy & Deirdre O Donovan CF Nurses

Changes in the management of children with Cystic Fibrosis. Caroline Murphy & Deirdre O Donovan CF Nurses Changes in the management of children with Cystic Fibrosis Caroline Murphy & Deirdre O Donovan CF Nurses What Is Cystic Fibrosis? Cystic fibrosis (CF) is an inherited chronic disease that primarily affects

More information

What is the inheritance pattern (e.g., autosomal, sex-linked, dominant, recessive, etc.)?

What is the inheritance pattern (e.g., autosomal, sex-linked, dominant, recessive, etc.)? Module I: Introduction to the disease Give a brief introduction to the disease, considering the following: the symptoms that define the syndrome, the range of phenotypes exhibited by individuals with the

More information

The McMaster at night Pediatric Curriculum

The McMaster at night Pediatric Curriculum The McMaster at night Pediatric Curriculum Community Acquired Pneumonia Based on CPS Practice Point Pneumonia in healthy Canadian children and youth and the British Thoracic Society Guidelines on CAP Objectives

More information

Evaluation of Patients with Diffuse Bronchiectasis

Evaluation of Patients with Diffuse Bronchiectasis Evaluation of Patients with Diffuse Bronchiectasis Dr. Patricia Eshaghian, MD Assistant Clinical Professor of Medicine Director, UCLA Adult Cystic Fibrosis Affiliate Program UCLA Division of Pulmonary

More information

Cystic fibrosis: hitting the target

Cystic fibrosis: hitting the target Cystic fibrosis: hitting the target Heartland Collaborative Annual Meeting Friday, October 5, 2012 Thomas Ferkol MD 1938 1953 Cystic fibrosis: a historical timeline Cystic fibrosis (CF) of the pancreas

More information

Community Acquired Pneumonia

Community Acquired Pneumonia April 2014 References: 1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL Mace SE, McCracken Jr. GH, Moor MR, St. Peter SD, Stockwell JA, and Swanson JT. The Management of

More information

Cystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis 5/01/2011 CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE. D ANDERSEN.

Cystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis 5/01/2011 CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE. D ANDERSEN. 1938 OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE. D ANDERSEN. American Journal Diseases Children. : The beginning May 1938: 49 cases 25 20 15 Nos of cases 10 5 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 Age

More information

Bronchiectasis in Adults - Suspected

Bronchiectasis in Adults - Suspected Bronchiectasis in Adults - Suspected Clinical symptoms which may indicate bronchiectasis for patients Take full respiratory history including presenting symptoms, past medical & family history Factors

More information

Cystic Fibrosis. Presented by: Chris Belanger & Dylan Medd

Cystic Fibrosis. Presented by: Chris Belanger & Dylan Medd Cystic Fibrosis Presented by: Chris Belanger & Dylan Medd Outline What is Cystic Fibrosis? Signs, Symptoms & Diagnosis Who does it effect? General effects on daily life Managing Cystic Fibrosis Exercise

More information

Daniel Hirsch, MD Director of Neonatology Somerset Medical Center Assistant Professor of Pediatrics UMDNJ RWJMS

Daniel Hirsch, MD Director of Neonatology Somerset Medical Center Assistant Professor of Pediatrics UMDNJ RWJMS Daniel Hirsch, MD Director of Neonatology Somerset Medical Center Assistant Professor of Pediatrics UMDNJ RWJMS Daniel Hirsch, MD Director of Neonatology Somerset Medical Center Assistant Professor of

More information

Rhianna Cenci, Sodexo Dietetic Intern

Rhianna Cenci, Sodexo Dietetic Intern Rhianna Cenci, Sodexo Dietetic Intern Objectives Overview of CF and Treatments CF Medical Nutrition Therapy CF Case Study Cystic Fibrosis (CF) Overview Inherited chronic disease Produces unusually thick

More information

SWISS SOCIETY OF NEONATOLOGY. Prenatal diagnosis and postnatal management of meconium pseudocysts

SWISS SOCIETY OF NEONATOLOGY. Prenatal diagnosis and postnatal management of meconium pseudocysts SWISS SOCIETY OF NEONATOLOGY Prenatal diagnosis and postnatal management of meconium pseudocysts September 2007 2 Burch E, Caduff JH, Hodel M, Berger TM, Neonatal and Pediatric Intensive Care Unit (BE,

More information

Cystic Fibrosis as it relates to the neonate MARIANNE MUHLEBACH, MD PROFESSOR, DEPT. PEDIATRICS UNC CHAPEL HILL

Cystic Fibrosis as it relates to the neonate MARIANNE MUHLEBACH, MD PROFESSOR, DEPT. PEDIATRICS UNC CHAPEL HILL Cystic Fibrosis as it relates to the neonate MARIANNE MUHLEBACH, MD PROFESSOR, DEPT. PEDIATRICS UNC CHAPEL HILL Objectives: At the end of the presentation the listeners will Be able to describe neonatal

More information

Pediatrics Grand Rounds 13 November University of Texas Health Science Center at San Antonio. Learning Objectives

Pediatrics Grand Rounds 13 November University of Texas Health Science Center at San Antonio. Learning Objectives Nationwide Newborn Screening for Cystic Fibrosis: Finally Creating an Opportunity for All Patients to Have Better Outcomes Philip M Farrell, MD, PhD* University of Wisconsin-Madison *No disclosures other

More information

Chapter 3 The Role of Nutrition in CF Care

Chapter 3 The Role of Nutrition in CF Care Chapter 3 The Role of Nutrition in CF Care S. King, N. Saxby & N. Sander Cystic fibrosis is the most common lethal autosomal recessive genetic condition affecting Caucasians 186,187. Over 3500 Australians

More information

Liver Disease in Cystic Fibrosis

Liver Disease in Cystic Fibrosis Liver Disease in Cystic Fibrosis Basic Overview Clinical Aspects Management What Is Cystic Fibrosis? Autosomal recessive disease W-1:3000, H-1:10,000, AA-1:15,000 Mutations of CFTR defective Cl - transport

More information

Dr. Arghya Samanta PG-3 Department of Pediatrics

Dr. Arghya Samanta PG-3 Department of Pediatrics Dr. Arghya Samanta PG-3 Department of Pediatrics A 3 year old male K/C/O B-cell Acute lymphoblastic leukemia Undergoing induction phase of chemotherapy On day 23 of induction Presented with - high grade

More information

CASE OF STAPH. AUREUS PNEUMONIA DR.VINAY BHOMIA MD

CASE OF STAPH. AUREUS PNEUMONIA DR.VINAY BHOMIA MD CASE OF STAPH. AUREUS PNEUMONIA DR.VINAY BHOMIA MD PATIENT S HISTORY Ambalal Labana a male aged 40 yrs came with c/o -- High grade fever with rigors 7 days --cough with white expectoration 7 days --Breathlessness

More information

Chronic lung diseases in children Simple choice 1. Finger clubbing is not characteristic for: a) Diffuse bronchiectasis b) Cystic fibrosis c)

Chronic lung diseases in children Simple choice 1. Finger clubbing is not characteristic for: a) Diffuse bronchiectasis b) Cystic fibrosis c) Chronic lung diseases in children Simple choice 1. Finger clubbing is not characteristic for: a) Diffuse bronchiectasis b) Cystic fibrosis c) Bronchiolitis obliterans d) Complicated acute pneumonia e)

More information

BRONCHOGENIC CARCINOMA CHALLENGES IN EVALUATION

BRONCHOGENIC CARCINOMA CHALLENGES IN EVALUATION BRONCHOGENIC CARCINOMA CHALLENGES IN EVALUATION GRAND ROUND WARD 7C DATE: 25 TH MARCH 2015 PRESENTER: DR E. SAYO FACILITATOR: DR J MECHA DEMOGRAPHIC DATA NAME : CM AGE: 69 YEARS ADDRESS : KIAMBU OCCUPATION:

More information

1 yr old girl presented with Fever on and off 3 months H/o frequent semisolid bulky stools 3 months Progressive abdominal distension 3 months Failure

1 yr old girl presented with Fever on and off 3 months H/o frequent semisolid bulky stools 3 months Progressive abdominal distension 3 months Failure Dr Rajasree S Dr Srinivas S, Dr Bagdi RK, Dr Satheesh C Apollo Childrens Hospital, Chennai 1 yr old girl presented with Fever on and off 3 months H/o frequent semisolid bulky stools 3 months Progressive

More information

**Cystic Fibrosis** Notes :

**Cystic Fibrosis** Notes : **Cystic Fibrosis** Notes : - the slides are included in the lecture. - everything in Italic is just important things from the old lecture. - It s easy lecture, even it seems long.. GOOD LUCK Cystic fibrosis

More information

Contents. In this lecture, we will discuss: Tuberculosis. Asthma. Cystic fibrosis. Bronchopulmonary dysplasia. Miss.kamlah

Contents. In this lecture, we will discuss: Tuberculosis. Asthma. Cystic fibrosis. Bronchopulmonary dysplasia. Miss.kamlah 1 Contents In this lecture, we will discuss: Tuberculosis. Asthma. Cystic fibrosis. Bronchopulmonary dysplasia. 2 Tuberculosis (TB) is caused by organism Mycobacterium tuberculosis, which is transmitted

More information

Respiratory Disorders. Dr Tanya Robertson

Respiratory Disorders. Dr Tanya Robertson Respiratory Disorders Dr Tanya Robertson Aims Overview of respiratory problems in children Diagnosis Management Asthma Cystic fibrosis Why are children different? Immune status Structure and function respiratory

More information

TB in Children. The diagnostic challenge. Ralph Diedericks Red Cross Hospital

TB in Children. The diagnostic challenge. Ralph Diedericks Red Cross Hospital TB in Children The diagnostic challenge Ralph Diedericks Red Cross Hospital TB in children Brief epidemiology Clinical issues in primary TB Cases Rates of TB infection 2005 TST survey reported a TB prevalence

More information

Respiratory Pharmacology: Treatment of Cystic Fibrosis

Respiratory Pharmacology: Treatment of Cystic Fibrosis Respiratory Pharmacology: Treatment of Cystic Fibrosis Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart

More information

FOR GENERAL PRACTITIONERS

FOR GENERAL PRACTITIONERS INFORMATION PACK FOR GENERAL PRACTITIONERS Presented by 2 CONTENTS Chapter Page No 1. What is Cystic Fibrosis (CF)?... 5 Definition Symptoms The Digestive System Signs & Symptoms Breast Feeding & Cystic

More information

'SWEAT TEST' RESULTS IN NORMAL PERSONS OF DIFFERENT AGES COMPARED WITH FAMILIES WITH FIBROCYSTIC DISEASE OF THE PANCREAS

'SWEAT TEST' RESULTS IN NORMAL PERSONS OF DIFFERENT AGES COMPARED WITH FAMILIES WITH FIBROCYSTIC DISEASE OF THE PANCREAS 'SWEAT TEST' RESULTS IN NORMAL PERSONS OF DIFFERENT AGES COMPARED WITH FAMILIES WITH FIBROCYSTIC DISEASE OF THE PANCREAS BY CHARLOTTE M. ANDERSON and MAVIS FREEMAN From the Clinical Research Unit, Royal

More information

Cystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012

Cystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012 Cystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012 INTRODUCTION PNEUMOTHORAX HEMOPTYSIS RESPIRATORY FAILURE Cystic Fibrosis Autosomal Recessive Genetically

More information

Dr. R. Pradheep. DNB Resident Pediatrics. Southern. Railway. Hospital.

Dr. R. Pradheep. DNB Resident Pediatrics. Southern. Railway. Hospital. Hyperbilirubinemia in an Infant Pradheep Railway Dr. R. DNB Resident Pediatrics. Southern Hospital. A 2 ½ month old male baby born out of 3 rd degree consanguinity presented to us with c/o yellow discolouration

More information

CYSTIC FIBROSIS Risk Factors Epidemiology Pathogenesis Defective protein synthesis (10%) Abnormal protein folding, processing & trafficking

CYSTIC FIBROSIS Risk Factors Epidemiology Pathogenesis Defective protein synthesis (10%) Abnormal protein folding, processing & trafficking CYSTIC FIBROSIS Risk Factors Caucasian Family history of CF Infection Exposure to allergens and tobacco Epidemiology Carrier frequency of 1 in 25 for Caucasians The most common lethal genetic disease affecting

More information

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP Community Acquired Pneumonia Abdullah Alharbi, MD, FCCP A 68 y/ male presented to the ED with SOB and productive coughing for 2 days. Reports poor oral intake since onset due to nausea and intermittent

More information

Respiratory Disease. Dr Amal Damrah consultant Neonatologist and Paediatrician

Respiratory Disease. Dr Amal Damrah consultant Neonatologist and Paediatrician Respiratory Disease Dr Amal Damrah consultant Neonatologist and Paediatrician Signs and Symptoms of Respiratory Diseases Cardinal Symptoms Cough Sputum Hemoptysis Dyspnea Wheezes Chest pain Signs and Symptoms

More information

CF: Information for Case Managers. Cindy Capen MSN, RN Pediatric Pulmonary Division University of Florida

CF: Information for Case Managers. Cindy Capen MSN, RN Pediatric Pulmonary Division University of Florida CF: Information for Case Managers Cindy Capen MSN, RN capencl@peds.ufl.edu Pediatric Pulmonary Division University of Florida About your speaker 25+ years in pulmonary Coordinator for CF Center and CF

More information

Cystic Fibrosis New Patient Binder Cystic Fibrosis Center Pediatric Pulmonary Division

Cystic Fibrosis New Patient Binder Cystic Fibrosis Center Pediatric Pulmonary Division An annotated table-of-contents for the Cystic Fibrosis New Patient Binder Pediatric Pulmonary Division Introduction This booklet is a summary of the key points in the detailed and comprehensive information

More information

Chronic obstructive lung disease. Dr/Rehab F.Gwada

Chronic obstructive lung disease. Dr/Rehab F.Gwada Chronic obstructive lung disease Dr/Rehab F.Gwada Obstructive lung diseases Problem is in the expiratory phase Lung disease Restrictive lung disease Restriction may be with, or within the chest wall Problem

More information

Case 1. Case Discussion. History. Present Illness. Impression. Physical Examination

Case 1. Case Discussion. History. Present Illness. Impression. Physical Examination Case 1 Case Discussion R1 林吉倡 2013 / 01 / 02 13-yo Male BW: 45 kg DAY1 16:35 pm C/C: Epigastric pain since this morning TPR: 36.5/94/18 BP:133/83 SpO2: 100% GCS: 15 Triage: 2 Present Illness Sudden-onset

More information

Instructions: Please bring these forms to your Physical Examination & TB Test and have the Doctor fill them out. (Where applicable)

Instructions: Please bring these forms to your Physical Examination & TB Test and have the Doctor fill them out. (Where applicable) Instructions: Please bring these forms to your Physical Examination & TB Test and have the Doctor fill them out. (Where applicable) 1. The physician s examination certification form. Ask your doctor to

More information

Clinical Radiological Pathological Conference

Clinical Radiological Pathological Conference Clinical Radiological Pathological Conference CASE 1: A 59-year-old female Housekeeper Live in Phuket, Thailand Progressive dyspnea for 1 year Present illness 1 year PTA : She developed dyspnea on exertion

More information

Unit II Problem 2 Pathology: Pneumonia

Unit II Problem 2 Pathology: Pneumonia Unit II Problem 2 Pathology: Pneumonia - Definition: pneumonia is the infection of lung parenchyma which occurs especially when normal defenses are impaired such as: Cough reflex. Damage of cilia in respiratory

More information

MANAGEMENT OF TUBERCULOSIS IN NEONATES AND YOUNG INFANTS

MANAGEMENT OF TUBERCULOSIS IN NEONATES AND YOUNG INFANTS MANAGEMENT OF TUBERCULOSIS IN NEONATES AND YOUNG INFANTS A Bekker FIDSSA Conference, 2017 OUTLINE Case Perinatal TB Approach to the TB-exposed newborn MOM AND BABY S Born by NVD at peripheral hospital

More information

A case of DYSELECTROLYTEMIA. Dr. Prathyusha Dr. Lalitha janakiraman s unit

A case of DYSELECTROLYTEMIA. Dr. Prathyusha Dr. Lalitha janakiraman s unit A case of DYSELECTROLYTEMIA Dr. Prathyusha Dr. Lalitha janakiraman s unit CASE SUMMARY 4 month old, female infant 1 st born to NC parents, term, b.wt: 3.25kg No neonatal hospitalization Attained head control

More information

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? Randall W. Brown, MD MPH AE-C Association of Asthma Educators Annual Conference July 20, 2018 Phoenix, Arizona FACULTY/DISCLOSURES Randall Brown,

More information

CLINICAL MEETING CASE PRESENTATION : by DR.K.ADITYA 1 ST yr PG DEPARTMENT OF PEDIATRICS

CLINICAL MEETING CASE PRESENTATION : by DR.K.ADITYA 1 ST yr PG DEPARTMENT OF PEDIATRICS CLINICAL MEETING 14-9-2017 CASE PRESENTATION : by DR.K.ADITYA 1 ST yr PG DEPARTMENT OF PEDIATRICS Case History Baby A Age: 7 months Male Baby Residence: Miryalguda, Nalgonda DOA : 17-8-17 around 5 PM Chief

More information

Case presentation. Dr REESAUL R

Case presentation. Dr REESAUL R Case presentation Dr REESAUL R Mr S. 25 years old Case 1 Ref on 06/ April /2006 to Chest Clinic from a private GP of Port Louis for : Cough + haemoptysis and dyspnoea Case 1(6/April/2006) Mr S Single 25

More information

Pass the salt please!

Pass the salt please! Pass the salt please! Electrolyte Disturbance in an Infant with Cystic Fibrosis Aneurin Young ST4 Trainee in Paediatrics Wessex Deanery Tracey Farnon Consultant Paediatrician Salisbury District Hospital

More information

PNEUMONIA IN CHILDREN. IAP UG Teaching slides

PNEUMONIA IN CHILDREN. IAP UG Teaching slides PNEUMONIA IN CHILDREN 1 INTRODUCTION 156 million new episodes / yr. worldwide 151 million episodes developing world 95% in developing countries 19% of all deaths in children

More information

Bronchitis. Anatomy of the Lungs The lungs allow us to fill our blood with oxygen. The oxygen we breathe is absorbed into our blood in the lungs.

Bronchitis. Anatomy of the Lungs The lungs allow us to fill our blood with oxygen. The oxygen we breathe is absorbed into our blood in the lungs. Bronchitis Introduction Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to the lungs. It causes shortness of breath, wheezing and chest tightness as well as a cough that

More information

Cystic Fibrosis 8/23/2014 GROWTH DEFICIENCY IN CYSTIC FIBROSIS IS

Cystic Fibrosis 8/23/2014 GROWTH DEFICIENCY IN CYSTIC FIBROSIS IS 8/23/214 GROWTH DEFICIENCY IN CYSTIC FIBROSIS IS OBSERVABLE AT BIRTH AND PREDICTIVE OF EARLY PULMONARY FUNCTION by Rebecca Joan Nelson Case Western Reserve University Cleveland, Ohio Thesis Advisor: Rebecca

More information

Cystic Fibrosis Foundation Patient Registry 2013

Cystic Fibrosis Foundation Patient Registry 2013 5/9/2015 Targeting CFTR to Treat Cystic Fibrosis: Small Molecule Therapy Mary Ellen Kleinhenz, MD Director, UCSF Adult Cystic Fibrosis Program Professor of Medicine UCSF Division of Pulmonary, Critical

More information

Agammaglobulinemia. Vilnius University Children s s Hospital Pediatric Center, R.Duobiene

Agammaglobulinemia. Vilnius University Children s s Hospital Pediatric Center, R.Duobiene Agammaglobulinemia Vilnius University Children s s Hospital Pediatric Center, R.Duobiene Case report R.B., male, born on February 1997. The parents are consanguineous. Eyes pathology in fathers family

More information

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Cystic Fibrosis Transmembrane Page 1 of 11 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Prime Therapeutics

More information

An unusual cause of pneumatocoele

An unusual cause of pneumatocoele An unusual cause of pneumatocoele From Dr.N.C.Gowrishankar s Unit Pediatric Surgery and PICU Dr Shashi Ranjani DNB PG Mehta Children Hospital 13 year boy h/o RTA at 2.30 pm boy was under the rear wheel

More information

Case conference. Welcome Dr. Lawrence Tierney

Case conference. Welcome Dr. Lawrence Tierney Case conference Welcome Dr. Lawrence Tierney Case: 18 year-old male CC) hamatomesis, Fever and cough HPI) 1 st admission One month ago, he admitted to our hospital because of hematemesis. He had weight

More information

Influenza-Associated Pediatric Deaths Case Report Form

Influenza-Associated Pediatric Deaths Case Report Form STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Form approved OMB No. 0920-0007 Last Name: First Name: County: Address: City: State, Zip: Patient Demographics 1. State: 2. County: 3. State

More information

Spleen indications of splenectomy complications OPSI

Spleen indications of splenectomy complications OPSI Intestinal obstruction Differences between adynamic ileus and mechanical obstruction Aetiology Pathophysiology (Cluster contractions- bowel proximal to the obstruction dilate- wall of obstructed gut is

More information

Chronic Cough An Unusual Presentation. Dr Sourabh Jain Department of Respiratory Medicine

Chronic Cough An Unusual Presentation. Dr Sourabh Jain Department of Respiratory Medicine Chronic Cough An Unusual Presentation Dr Sourabh Jain Department of Respiratory Medicine A 72 years old male from Pune, non smoker, with no co-morbidities Chief Complaints : Chronic cough with scanty mucoid

More information

Exam 1 Review. Cardiopulmonary Symptoms Physical Examination Clinical Laboratory Studies

Exam 1 Review. Cardiopulmonary Symptoms Physical Examination Clinical Laboratory Studies Exam 1 Review Cardiopulmonary Symptoms Physical Examination Clinical Laboratory Studies WBC Count Differential A patient had been admitted to the hospital for acute shortness of breath. A CXR examination

More information

Cystic Fibrosis Diagnosis and Treatment

Cystic Fibrosis Diagnosis and Treatment Cystic Fibrosis Diagnosis and Treatment Financial Disclosures Personal financial relationships with commercial interests relevant to medicine, within the past 3 years: NJH site PI for AstraZeneca. As faculty

More information

HOW DISEASE ALTERING THERAPY IS CHANGING THE GOALS OF TREATMENT IN CF

HOW DISEASE ALTERING THERAPY IS CHANGING THE GOALS OF TREATMENT IN CF HOW DISEASE ALTERING THERAPY IS CHANGING THE GOALS OF TREATMENT IN CF Peter D. Sly MBBS, MD, FRACP, DSc OUTLINE Goals of CF treatment Drivers of early disease neutrophilic inflammation oxidative stress

More information

Chronic Pancreatitis (1 of 4) i

Chronic Pancreatitis (1 of 4) i Chronic Pancreatitis (1 of 4) i If you need this information in another language or medium (audio, large print, etc) please contact the Customer Care Team on 0800 374 208 email: customercare@ salisbury.nhs.uk.

More information

THE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF)

THE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF) THE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF) Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA 02210. Vertex and the Vertex triangle logo are registered trademarks for Vertex

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Cystic Fibrosis Transmembrane Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Prime Therapeutics

More information

PATIENT EDUCATION. Cystic Fibrosis Carrier Testing

PATIENT EDUCATION. Cystic Fibrosis Carrier Testing PATIENT EDUCATION Cystic Fibrosis Carrier Testing Introduction Cystic fibrosis carrier testing before or during pregnancy can help determine your risk of having a child with cystic fibrosis. This information

More information

Anatomy of the biliary tract

Anatomy of the biliary tract Harvard-MIT Division of Health Sciences and Technology HST.121: Gastroenterology, Fall 2005 Instructors: Dr. Jonathan Glickman Anatomy of the biliary tract Figure removed due to copyright reasons. Biliary

More information

Chapter 22. Pulmonary Infections

Chapter 22. Pulmonary Infections Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired

More information

GOALS AND INSTRUCTIONAL OBJECTIVES

GOALS AND INSTRUCTIONAL OBJECTIVES October 4-7, 2004 Respiratory GOALS: GOALS AND INSTRUCTIONAL OBJECTIVES By the end of the week, the first quarter student will have an in-depth understanding of the diagnoses listed under Primary Diagnoses

More information

Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center

Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center Kathy Peters is a 63 y.o. patient that presents to your urgent care office today with a history

More information

PEDIATRIC INFLUENZA CLINICAL PRACTICE GUIDELINES

PEDIATRIC INFLUENZA CLINICAL PRACTICE GUIDELINES PEDIATRIC INFLUENZA CLINICAL PRACTICE GUIDELINES DEFINITIONS AND BACKGROUND Uncomplicated influenza illness is characterized by the abrupt onset of constitutional and respiratory signs and symptoms. Signs

More information

Dr.V.Akila Devi DNB PG Southern Railway Headquarters Hospital Chennai

Dr.V.Akila Devi DNB PG Southern Railway Headquarters Hospital Chennai Dr.V.Akila Devi DNB PG Southern Railway Headquarters Hospital Chennai 9 /12, male infant 3 rd born, NCM Not gaining motor mile stones appropriate for age Recurrent respiratory tract infections x 3 months

More information

Abdo Pain rules & regulations. Mark Hartnell 2010

Abdo Pain rules & regulations. Mark Hartnell 2010 Abdo Pain rules & regulations Mark Hartnell 2010 Aims Simple rules which might help in patients with abdominal pain Talk about some myths and realities Discuss some practical how to s in day to day treatment

More information

Interpret clinical and laboratory tests to identify conditions that require surgical intervention, including:

Interpret clinical and laboratory tests to identify conditions that require surgical intervention, including: Pediatric Surgery Note: The goals and objectives described in detail below are not meant to be completed in a single one month block rotation but are meant to be cumulative, culminating in a thorough and

More information

Lung Cancer - Suspected

Lung Cancer - Suspected Lung Cancer - Suspected Shared Decision Making Lung Cancer: http://www.enhertsccg.nhs.uk/ Patient presents with abnormal CXR Lung cancer - clinical presentation History and Examination Incidental finding

More information

The Cystic Fibrosis Gene. about. CF is one of the most common genetic diseases that cause death in both children and

The Cystic Fibrosis Gene. about. CF is one of the most common genetic diseases that cause death in both children and Gill1 Peter Gill Malory Klocke Research Paper 02 August, 2011 The Cystic Fibrosis Gene Cystic fibrosis, better known as CF, is a genetic disease most people know very little about. CF is one of the most

More information

Pediatric Case Studies. Case 1

Pediatric Case Studies. Case 1 Pediatric Case Studies James Naprawa, MD Assistant Clinical Professor Pediatric Emergency Medicine Children s Hospital, Columbus Case 1 Almost 4 year old AA girl PMH UTI x 2 with abdominal pain and fever

More information

Comparison of Classic Sweat Test and Crystallization Test in Diagnosis of Cystic Fibrosis

Comparison of Classic Sweat Test and Crystallization Test in Diagnosis of Cystic Fibrosis Original Article Iran J Pediatr Mar 2012; Vol 22 (No 1), Pp: 102-106 Comparison of Classic Sweat Test and Crystallization Test in Diagnosis of Cystic Fibrosis Fatemeh Farahmand 1,2, MD; Nooshin Sadjadei

More information

The University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Pulmonary

The University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Pulmonary The University of Arizona Pediatric Residency Program Primary Goals for Rotation Pulmonary 1. GOAL: Diagnose and manage patients with asthma. 2. GOAL: Understand the role of the pediatrician in preventing

More information

Cystic Fibrosis in Bahrain Incidence, Phenotype, and Outcome

Cystic Fibrosis in Bahrain Incidence, Phenotype, and Outcome Cystic Fibrosis in Bahrain Incidence, Phenotype, and Outcome by Fadheela Al-Mahroos, MD, FAAP Sulmanyia Medical Center, Arabian Gulf University, Bahrain Summary To identify the incidence and evaluate the

More information

PERSISTENT DIARRHOEA. IAP UG Teaching slides

PERSISTENT DIARRHOEA. IAP UG Teaching slides PERSISTENT DIARRHOEA 1 DEFINITION Prolongation of acute diarrhoea / dysentery for more than 14 days Generally associated with weight loss. 2 PROTRACTED DIARRHOEA Prolongation of acute diarrhoea or dysentery

More information

Approach to a case of Neonatal Cholestasis

Approach to a case of Neonatal Cholestasis Approach to a case of Neonatal Cholestasis Ira Shah (Co-Incharge, Consultant Pediatrician, Pediatric Liver Clinic) Gunjan Narkhede (Resident in Pediatric Liver Clinic) Pediatric Hepatobiliary Clinic, B.J.Wadia

More information

Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No

Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No. 0920-0004 STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Last Name: First Name: County: Address: City: State,

More information

Shally Awasthi Professor of Pediatrics Chhatrapati Shahuji Maharaj Medical University, Lucknow

Shally Awasthi Professor of Pediatrics Chhatrapati Shahuji Maharaj Medical University, Lucknow Shally Awasthi Professor of Pediatrics Chhatrapati Shahuji Maharaj Medical University, Lucknow Magnitude of problem Misclassification of pneumonia Inappropriate use of antibiotics Inadequate Surveillance

More information

Short Cases M I CHA E L DE RYNCK, M D U N I V ERSITY OF CA LG A RY F E BR UA RY

Short Cases M I CHA E L DE RYNCK, M D U N I V ERSITY OF CA LG A RY F E BR UA RY Short Cases MICHAEL DERYNCK, MD UNIVERSITY OF CALGARY FEBRUARY 15 2018 Case 1: Beyond Bronchiolitis Presentation 2 month old, term girl Cough and rhinitis, increased work of breathing, wheeze and apnea

More information

PULMONARY SURFACTANT, ALPHA 1 ANTITRYPSIN INHIBITOR DEFICIENCY, AND CYSTIC FIBROSIS DR. NABIL BASHIR BIOCHEMISTRY/RESPIRATORY SYSTEM

PULMONARY SURFACTANT, ALPHA 1 ANTITRYPSIN INHIBITOR DEFICIENCY, AND CYSTIC FIBROSIS DR. NABIL BASHIR BIOCHEMISTRY/RESPIRATORY SYSTEM PULMONARY SURFACTANT, ALPHA 1 ANTITRYPSIN INHIBITOR DEFICIENCY, AND CYSTIC FIBROSIS DR. NABIL BASHIR BIOCHEMISTRY/RESPIRATORY SYSTEM Pulmonary surfactant Pulmonary surfactant is (phospholipoprotein) complex

More information

Caring for a person with cystic fibrosis

Caring for a person with cystic fibrosis Caring for a person with cystic fibrosis Item Type Article Authors McDonagh, Yvonne;Meagher, Catherine Publisher Green Cross Publishing Journal Nursing in General Practice Download date 01/09/2018 03:18:31

More information

COMMON VARIABLE IMMUNODEFICIENCY

COMMON VARIABLE IMMUNODEFICIENCY COMMON VARIABLE IMMUNODEFICIENCY This booklet is intended for use by patients and their families and should not replace advice from a clinical immunologist. 1 COMMON VARIABLE IMMUNODEFICIENCY Also available

More information

Welcome to Nutrition Management of Cystic Fibrosis by Lolita McLean, MPH, RDN; Connie Martin, MS, RDN; and Claire Stephens, MS, RDN...

Welcome to Nutrition Management of Cystic Fibrosis by Lolita McLean, MPH, RDN; Connie Martin, MS, RDN; and Claire Stephens, MS, RDN... Welcome to Nutrition Management of Cystic Fibrosis by Lolita McLean, MPH, RDN; Connie Martin, MS, RDN; and Claire Stephens, MS, RDN...all of Alabama s Children s Rehabilitation Service, or CRS, part of

More information